You can email us at, or call us on 01202 539791.Email: Phone: 01202 539791.



Repaglinide is a potent short-acting insulin secretagogue that acts by closing ATP-sensitive potassium (KATP) channels in the plasma membrane of the pancreatic beta cell. It represents a new class of insulin secretagogues, structurally unrelated to sulphonylureas, which were developed for the treatment of type 2 diabetes.

Product Details

Category Diabetes Research
Price POA
CAS Number 135062-02-1
Formula C27H36N2O4
Molecular Weight 452.59
Purity 98.0%
Appearance white solid
Availability In Stock
Storage Conditions +4°C

Product Enquiry

Send us your enquiry for Repaglinide. We offer custom pack sizes at special prices. We aim to respond to your enquiry within 24 hours.

We value your input so if you have suggestions regarding new applications for Repaglinide email us and we will include your contribution on the website.

Enquire about product

Back to Top